Td Asset Management Inc Vertex Pharmaceuticals Inc Transaction History
Td Asset Management Inc
- $107 Billion
- Q3 2024
A detailed history of Td Asset Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Td Asset Management Inc holds 522,205 shares of VRTX stock, worth $214 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
522,205
Previous 504,054
3.6%
Holding current value
$214 Million
Previous $236 Million
2.8%
% of portfolio
0.23%
Previous 0.23%
Shares
29 transactions
Others Institutions Holding VRTX
# of Institutions
1,725Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$11 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.49 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.73 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.84 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.69 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $105B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...